Discrepancy between long-term and previously published analysis for osteonecrosis of the jaw under denosumab

Paul de Boissieu^{1

2}, Thierry Trenque^{3

4}

Affiliations

¹ Department of Pharmacovigilance and Pharmacoepidemiology, Reims University Hospitals, Avenue du Général Koenig, 51100, Reims, France. pdeboissieu@chu-reims.fr.
² Faculty of Medicine, University of Reims Champagne-Ardenne, EA3797, Reims, France. pdeboissieu@chu-reims.fr.
³ Department of Pharmacovigilance and Pharmacoepidemiology, Reims University Hospitals, Avenue du Général Koenig, 51100, Reims, France.
⁴ Faculty of Medicine, University of Reims Champagne-Ardenne, EA3797, Reims, France.

PMID: 27121570
DOI: 10.1007/s00520-016-3238-7

Comment

Discrepancy between long-term and previously published analysis for osteonecrosis of the jaw under denosumab

Paul de Boissieu et al. Support Care Cancer. 2017 Feb.

. 2017 Feb;25(2):351-352.

doi: 10.1007/s00520-016-3238-7. Epub 2016 Apr 28.

Authors

Paul de Boissieu^{1

2}, Thierry Trenque^{3

4}

Affiliations

¹ Department of Pharmacovigilance and Pharmacoepidemiology, Reims University Hospitals, Avenue du Général Koenig, 51100, Reims, France. pdeboissieu@chu-reims.fr.
² Faculty of Medicine, University of Reims Champagne-Ardenne, EA3797, Reims, France. pdeboissieu@chu-reims.fr.
³ Department of Pharmacovigilance and Pharmacoepidemiology, Reims University Hospitals, Avenue du Général Koenig, 51100, Reims, France.
⁴ Faculty of Medicine, University of Reims Champagne-Ardenne, EA3797, Reims, France.

PMID: 27121570
DOI: 10.1007/s00520-016-3238-7

No abstract available

PubMed Disclaimer

Comment in

Response to letter to the Editors-Safety of long-term denosumab therapy.
Stopeck AT, Warner DJ. Stopeck AT, et al. Support Care Cancer. 2017 Feb;25(2):353-355. doi: 10.1007/s00520-016-3492-8. Epub 2016 Nov 24. Support Care Cancer. 2017. PMID: 27885467 Free PMC article. No abstract available.

Comment on

Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer.
Stopeck AT, Fizazi K, Body JJ, Brown JE, Carducci M, Diel I, Fujiwara Y, Martín M, Paterson A, Tonkin K, Shore N, Sieber P, Kueppers F, Karsh L, Yardley D, Wang H, Maniar T, Arellano J, Braun A. Stopeck AT, et al. Support Care Cancer. 2016 Jan;24(1):447-455. doi: 10.1007/s00520-015-2904-5. Epub 2015 Sep 3. Support Care Cancer. 2016. PMID: 26335402 Free PMC article. Clinical Trial.

Cited by

Response to letter to the Editors-Safety of long-term denosumab therapy.
Stopeck AT, Warner DJ. Stopeck AT, et al. Support Care Cancer. 2017 Feb;25(2):353-355. doi: 10.1007/s00520-016-3492-8. Epub 2016 Nov 24. Support Care Cancer. 2017. PMID: 27885467 Free PMC article. No abstract available.

References

1. J Clin Oncol. 2010 Dec 10;28(35):5132-9 - PubMed
1. Lancet. 2011 Mar 5;377(9768):813-22 - PubMed
1. Support Care Cancer. 2016 Jan;24(1):447-55 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Discrepancy between long-term and previously published analysis for osteonecrosis of the jaw under denosumab

Affiliations

Discrepancy between long-term and previously published analysis for osteonecrosis of the jaw under denosumab

Authors

Affiliations

Comment in

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical